funding PI
CO-PI
Grant Title
Agency
Type
Total Amount Current Amount
current period
McCay E
Beanlands H, Cooper L, Hughes J, Hwang S, Karabanow J, Langley J, MacLaurin B, McMain S, Quesnel S, Sidani S, Worthington C
Enhancement of Transitional Housing Programmes for Streetinvolved Youth through the Application of Dialectical
CIHR
Operating Grant
$329,792.00
$130,179.00
01/11/2011 to 31/10/2012
McCay E
Romano D, Langley J, Archie S, Cheng C, Conrad G, Manchanda R, Menezes N, Roy P, Tibbo P, Beanlands H, Dewa C, Rose D, Santa Mina E, Schwind J, Zipursky R, Aiello A, Rehder M, Gehrs M, Robinson K, Jeffs L, Norman R
Sustaining Recovery: Supporting CIHR the Transition from Specialized Services to Primary Care for AtRisk Youth Who Have Experienced a First Episode of Psychosis
Travel Conference
$25,000.00
$25,000.00
01/02/2011 to 31/01/2012
McDonald SD
Mueller VM, Bracken K, Brouwers MC, McDonald HC, Pullenayegum EM, Sword WA, Taylor VH
Developing interventions to pre- CIHR vent excess maternal weight gain and its consequences: Improving the translation of guidelines into practice (The IMPROVE Study)
Operating Grant
$199,679.00
$199,679.00
01/04/2011 to 31/03/2012
McDonell J Wolfe DA
A multi-level, cohort-sequential study of rural adolescent dating violence victimization and perpetration
NICHHD
Operating Grant
$1,875,000.00
$455,000.00
02/09/2011 to 31/08/2012
McIntyre RS
Intranasal Insulin and Major Depressive Disorder.
NARSAD
Operating Grant
$100,000.00
$12,500.00
01/07/2011 to 31/12/2011
A Randomized, Double-blind, Placebo-Controlled Trial Evaluating the Effects of Intranasal Insulin of Cognitive Function in Euthymic Individuals with Major Depressive Disorder.
NARSAD
Operating Grant
$99,360.00
$20,000.00
01/07/2011 to 30/06/2012
McIntyre RS
Kennedy SH, Lewis G, MacQueen G, McKinnon M, Konarski, J
Mcintyre RS
The Quietude Study: Comparing Astra Zeneca the Effectiveness of Escitalopram to Quetiapine XR in the Treatment of Agitated Depression.
Operating Grant
$1,600,000.00
$-
01/01/2011 to 01/12/2012
McIntyre RS
A Multicentre, Double-Blind, Randomised, Parallel Group, Escitalopram Controlled Phase III-B Study of the Efficacy and Safety of Quetiapine Fumarate Extended Release (Seroquel XRTM) as Monotherapy in the Treatment of Adult Patients with Agitated MDD.
Contract
$1,600,000.00
$800,000.00
01/09/2011 to 31/08/2012
Other